NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement

NCT01408472 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma, Primary Open Angle

Interventions

DRUG: NT-501 CNTF Implant

Sponsor

Jeffrey L Goldberg